![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Global | Publication | November 2023
Marta Giner Asins and Arnaud Sanz of our Paris office are the authors of a chapter on product denigration that has been published in the second edition of the Global Competition Review’s The Guide to Life Sciences 2023. This chapter discusses a number of recent cases undertaken by the French competition authority that have progressively widened the definition of denigration and the standard applicable to relations with authorities.
Whilst the approach adopted in the life sciences sector is particularly strict, denigration decisions have also been adopted in areas such as energy or telecommunications. The authors address as well cases on denigration in the life sciences sector initiated by other national Competition Authorities.
An extract from Global Competition Review’s The Guide to Life Sciences 2023, can be accessed here, provided with the kind permission of the publishers, Global Competition Review.
The whole publication is available here.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023